The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast. These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or rescntr@ire.org) where a researcher can help you pinpoint what you need. Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:
Search results for "blood clots" ...
-
Dangerous Remedy
Robert Little of The (Baltimore) Sun reported that the U.S. Army has injected over 1000 soldiers wounded in Iraq with a medicine designed for hemophiliacs despite the fact that it is dangerous for people with normal blood. It can give them blood clots that could cause strokes and heart attacks. It costs $6000 per dose. Civilian doctors "have largely rejected it as a standard treatment for trauma patients." Army doctors say, in their experience, the drug saves lives by stopping hemorrhaging. Little says “Doctors in Iraq's emergency rooms, however, almost never care for their patients long enough to see firsthand whether blood clots or other complications have developed." Little reports that "the drug has never been subjected to a large-scale clinical trial to verify that it works and is safe for patients without hemophilia."
Tags: military medical system; Iraq; coagulant; Institute for Surgical Research; Germany; military hospitals; Food and Drug Administration; FDA; U.S. Department of Defense; DoD; Marines; Assistant Secretary of Defense for Health Affairs; U.S. Army Surgeon General; HIPPA; actionable intelligence; Recombinant Activated Factor VII; Novo Nordisk; coagulopathic bleeding;
-
Patch Problems
A review of Food and Drug Administration records indicated that at least 12 women who used the birth-control patch died from blood clots in 2004, and that the risk of dying or suffering a survivable blood clot while using the device was about three times higher than while using birth control pills.
Tags: birth control; Food and Drug Administation; death; blood clots
-
The death of Keisha
The author investigated the death of LaKeisha Brown in the custody of Alexander Youth Services Center. The girl's repeated requests for help over a period of days were brushed off by nurses at the juvenile lockup, and they were by the facility supervisors. The only medical attention she received the day of her death was some Advil and a puff of her inhaler. The medical examiner found that Keisha had died a slow death from blood clots in her lungs that had been there for a minimum of two days and up to two weeks.
Tags: juvenile facilities; Department of Justice; LaKeisha Brown; medical intervention; Youth Services; FOIA
-
Vaccine Dangers
The news team found risks had been concealed from people asked to take the smallpox vaccines. They also expose the military's refusal to admit its vaccines are harming some soldiers; soldiers who are often dismissed and treated like "malingerers." They focused on the case of Rachael Lacy. The military denied her death was from the vaccines it administered but the news team found her death certificate showed otherwise. They also looked at the case of NBC War Correspondent David Bloom who died after his vaccinations. His case was not reported or investigated as a possible vaccine adverse event. They also looked at a Journal of the American Medical Association claiming there had been "no" deaths after smallpox vaccinations.
Tags: TAPE; military; smallpox; vaccine; medical records; death; death certificate; military casualty record; inoculation; blood clots; Anthrax; pulmonary nodules; Food and Drug Administration; Defense Department; bio-terror attack; Rachael Lacy; David Bloom; immune system
-
Hidden Casualties: Mark Benjamin's reporting on sick, injured and wounded U.S. troops
After revealing that hundreds of National Guard and Reserve Soldiers in medical hold at Fort Stewart, Ga., were being kept in hot cement barracks, UPI further investigates the issue of sick, injured and wounded U.S troops. The investigation reveals that conditions similar to Fort Stewart also prevail in Fort Knox. Further, the report includes a detailed account linking a number of U.S non-combat illnesses and deaths in Iraq and elsewhere to possible side effects of anthrax and smallpox vaccines. Also, after the death of NBC reporter David Bloom from a blood clot in Iraq, Benjamin started tracking other cases in which soldiers there and in the U.S had become sick or died from blood clots after getting their vaccines.
Tags: National Gulf Resource Center; Army Secretary Less Brownlee; Senate National Guard Caucus
-
The Trials of an Artificial Heart
The quest for replacing a failing human heart with a mechanical device received a boost when a company named Abiomed developed AbioCor. The initial clinical trials of this grapefruit-sized plastic-and-titatnium machine were encouraging. However, it was later found that five of the seven persons on whom AbioCor was tried, died. Abiomed officials argue that the artificial heart is proving its worth, however, they also acknowledge that a flaw in the device's attachments to the body might have led to the formation of blood clots causing fatal heart strokes.
-
Off the Label: Staffers of Drug Maker Say It Pushed Product For Unapproved Use
The Journal reports on how doctors, paid by pharmaceutical companies, promote medicines before they are approved by the Food and Drug Administration or for off-label uses. The story focuses on the marketing practices of Rhone-Poulenc Rorer, known as RPR, producer of a new kind of drug for blood clots, called Lovenox.
Tags: medicine; health care; doctors; lawsuits; justice; Rhone-Poulenc Rorer; prescription drugs
-
Abbokinase
A KTVU Channel 2 News investigation of the risks "associated with a clot-busting agent known as Abbokinase" revealed that a source of the drug, stillborn infants, poses a potential risk of spreading disease and is surrounded by serious ethical issues.
Tags: TAPE TRANSCRIPT Abbokinase health care; ethics; blood clots FDA Food and Drug Administration Abbott Laboratories Coli; Columbia human tissue research
-
No title (id: 12568)
In the late 1970s and early 1980s, as many as 10,000 hemophiliacs in the United States were infected with the AIDS virus from blood-clotting medicines made with human plasma. Today, they are dying at the rate of one a day. The plasma-products industry has portrayed this as an unforeseeable tragedy that could not have been prevented. The Philadelphia Inquirer investigation showed otherwise. (Aug. - Dec., 1995)
Tags: Shaw CAR Blood money and AIDS Contest entry HIV FOIA 48 pgs.
-
No title (id: 5601)
Barron's looks at Genentech's new drug for heart-attack victims, TPA; the drug was promoted as the miracle medicine that could dissolve blood clots, but the FDA may have approved it too quickly; finds side effects include fatal reactions such as cerebral hemorrhaging, Jan. 11 and Nov. 21, 1988.
Tags: Mahar Genentech TPA